Hyalex Orthopaedics is a Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX materials technology. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. HYALEX Orthopaedics' products are in the development stage and have not been approved for use in humans by any regulatory agency.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
06/01/17 | $16,000,000 | Series A |
Canaan Partners Johnson & Johnson Innovation Osage University Partners | undisclosed |